Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | September 2009 |
| End Date: | August 2011 |
| Contact: | Stephen Oh |
| Email: | stoh@stanford.edu |
| Phone: | (650) 723-7875 |
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
The objective of this study is to better understand the underlying pathogenetic mechanisms
of MPDs. We will collect peripheral blood samples from MPD patients and utilize
multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in
blood cells from these patients. This will provide deeper insights into the pathogenesis of
MPDs and may lead to the identification of novel targets for therapeutic intervention.
of MPDs. We will collect peripheral blood samples from MPD patients and utilize
multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in
blood cells from these patients. This will provide deeper insights into the pathogenesis of
MPDs and may lead to the identification of novel targets for therapeutic intervention.
Inclusion Criteria:Any patient who carries a diagnosis of a myeloproliferative disorder
(MPD).
Exclusion Criteria:Any patient who is not willing to give consent.
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
